Table 1 Monthly average of commercial units of antibiotics sold in Brazil for children aged 1–12 years, between 2014 and 2019 and during the pandemic period (Jan 2020 to July 2021).
From: Impact of COVID-19 on antibiotic prescriptions for Brazilian children
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Pandemic | Sales Reduction (%) | |
|---|---|---|---|---|---|---|---|---|
Amoxicillin | 460,879 | 485,696 | 514,597 | 586,303 | 576,264 | 603,683 | 186,655 | 65.3* |
Azithromycin | 137,195 | 149,734 | 165,952 | 186,835 | 188,782 | 198,973 | 110,989 | 35.1* |
Cefalexin | 101,731 | 108,492 | 119,554 | 116,504 | 111,688 | 112,854 | 73,262 | 34.4* |
SXT | 49,747 | 53,221 | 53,180 | 50,007 | 45,185 | 45,841 | 26,990 | 45.5* |
Ceftriaxone | 46,871 | 40,391 | 31,520 | 40,286 | 40,894 | 43,614 | 15,667 | 61.4* |
Cefadroxil | 13,542 | 12,943 | 12,330 | 11,870 | 11,063 | 10,947 | 5403 | 55.4* |
Metronidazole | 20,898 | 19,611 | 19,986 | 17,668 | 11,313 | 12,818 | 8834 | 48.1* |
Levofloxacin | 4,414 | 5,179 | 6,306 | 7,249 | 7376 | 6750 | 3990 | 35.7* |
Penicillin G benzathine | 2,445 | 2,908 | 5,088 | 3,836 | 2,644 | 3460 | 1847 | 45.6* |
Erythromycin | 6,823 | 5,364 | 3,856 | 2,786 | 225 | 8 | 1 | 99.9* |
Total | 806,137 | 883,539 | 932,369 | 1,023,344 | 995,434 | 1,038,948 | 433,637 | 54.1* |